X0609 4 2026-10-01 0001447028 Arbutus Biopharma Corp [ABUS] 0001635088 Roivant Sciences Ltd. true C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY LONDON X0 X0 SW1H0DB UNITED KINGDOM true false true false false Common Shares 2026-10-01 4 D false 8967383 5.00 D 29880079 D The Reporting Person may be deemed to be a "director by deputization" of the Issuer for purposes of Section 16 of the Securities Exchange Act of 1934 by virtue of the fact that Matthew Gline (a director of the Issuer who serves as Chief Executive Officer of the Reporting Person and is an employee of Roivant Sciences, Inc. ("RSI"), a subsidiary of the Reporting Person) and Joseph Bishop (who is an employee of RSI) each currently serve on the board of directors of the Issuer on behalf of the Reporting Person. Lindsay Androski, who also serves on the board of directors of the Issuer, is an employee of RSI and separately serves as President and Chief Executive Officer of the Issuer. By: /s/ Keyur Parekh, as Authorized Signatory 2026-10-05